Critical illness-related corticosteroid insufficiency

Chest

Volumn 135, Issue 1, 2009, Pages 181-193

  Marik, Paul E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adrenal failure; ARDS; Corticosteroid insufficiency; Cortisol; Critical illness; Glucocorticoid receptor; Sepsis; Septic shock; Systemic inflammatory response syndrome

Indexed keywords

CORTICOSTEROID;

ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; CRITICAL ILLNESS; CRITICAL ILLNESS RELATED CORTICOSTEROID INSUFFICIENCY; HORMONE RESISTANCE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTENSIVE CARE UNIT; PRIORITY JOURNAL; REVIEW; SEPSIS; SYNDROME;

EID: 58249105731     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1149     Document Type: Article

References (127)

1. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 136:32-34
2. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332:1351-1362
3. Carrasco GA, Van de Kar LD, Carrasco GA. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463:235-272
4. Miller DB, O'Callaghan JP, Miller DB, et al. Neuroendocrine aspects of the response to stress. Metab Clin Exp 2002; 51:5-10
5. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53:58-68
6. Mueller UW, Potter JM. Binding of cortisol to human albumin and serum: the effect of protein concentration. Biochemical Pharmacology 1981; 30:727-733
7. Ho JT, Al-Musalhi H, Chapman MJ, et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levles. J Clin Endocrinol Metab 2006; 91:105-114
8. Dimopoulou I, Alevizopoulou P, Dafni U, et al. Pituitary-adreanl response to human corticotropin-releasing hormone in critically ill patients. Intensive Care Med 2007; 33:454-459
9. Arlt W, Stewart PM. Adrenal corticosteroid biosynthesis, metabolism, and action. Endocrinol Metab Clin North Am 2005; 34:293-313
10. Borkowski AJ, Levin S, Delcroix C, et al. Blood cholesterol and hydrocortisone production in man: quantitative aspects of the utilization of circulating cholesterol by the adrenals at rest and under adrenocorticotropin stimulation. J Clin Invest 1967; 46:797-811
11. Yaguchi H, Tsutsumi K, Shimono K, et al. Involvement of high density lipoprotein as substrate cholestrol for steroidogenesis by bovine adrenal fasciculo-reticularis cells. Life Sci 1998; 62:1387-1395
12. Acton S, Rigotti A, Landschultz KT, et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271:518-520
13. Calco D, Gomez-Coronado D, Lasuncion MA, et al. CLA-I is an 85-kD plasma membrane glycoprotein that acts as a high affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler Thromb Vasc Biol 1997; 17:2341-2349
14. de la Llera-Moya M, Connelly MA, Drazul D, et al. Scavenger receptor class B type 1 affects cholestrol homeostasis by magnifying cholestrol flux between cells and HDL. J Lipid Res 2001; 42:1969-1978
15. Liu J, Heikkila P, Meng QH, et al. Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol 2000; 142:677-682
16. Cai L, Ji A, de Beer FC, et al. SR-B1 protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 2008; 118:364-375
17. Rogerson FM, Fuller PJ. Interdomain interactions in the mineralocorticoid receptor. Mol Cell Endocrinol 2003; 200:45-55
18. Edwards CR, Stewart PM, Burt D, et al. Localisation of 11 β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988; 2:986-989
19. Funder JW, Pearce PT, Smith R, et al. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242:583-585
20. Tomlinson JW, Moore J, Cooper MS, et al. Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001; 142:1982-1989
21. Cai TQ, Wong B, Mundt SS, et al. Induction of 11beta-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. J Steroid Bioch Mol Biol 2001; 77:117-122
22. Oakley RH, Jewell CM, Yudt MR, et al. The dominant negative activity of the human glucocorticoid receptor beta isoform: specificity and mechanisms of action. J Biol Chem 1999; 274:27857-27866
23. Lewis-Tuffin LJ, Jewell CM, Bienstock RJ, et al. Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol Cell Biol 2007; 27:2266-2282
24. Lu NZ, Collins JB, Grissom SF, et al. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol Cell Biol 2007; 27:7143-7160
25. Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 2006; 102:11-21
26. Elbi C, Walker DA, Romero G, et al. Molecular chaperones function as steroid receptor nuclear mobility factors. Proc Natl Acad Sci U S A 2004; 101:2876-2881
27. Adcock IM, Caramori G, Ito K. New insights into the molecular mechanisms of corticosteroids actions. Curr Drug Targets 2006; 7:649-660
28. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004; 329:480-489
29. Minneci PC, Deans KJ, Banks SM, et al. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004; 141:47-56
30. McKee JI, Finlay WE. Cortisol replacement in severely stressed patients [letter]. Lancet 1983; 1:484
31. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005; 171:242-248
32. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
33. Meduri GU, Golden E, Freire AX, et al. Methyprednisolone infusion in patients with early severe ARDS: results of a randomized trial. Chest 2007; 131:954-963
34. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Crit Care Med. Crit Care Med 2008; 36:1937-1949
35. Scammell JG, Denny WB, Valentine DL, et al. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen Comparat Endocrinol 2001; 124:152-165
36. Westberry JM, Sadosky PW, Hubler TR, et al. Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51. J Steroid Biochem Mol Biol 2006; 100:34-41
37. Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005; 352:1967-1976
38. Hew M, Bhavsar P, Torrego A, et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006; 174:134-141
39. Chikanza IC, Kozaci DL. Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives. Rheumatology 2004; 43:1337-1345
40. Chikanza IC, Kozaci D, Chernajovsky Y. The molecular and cellular basis of corticosteroid resistance. J Endocrinol 2003; 179:301-310
41. Meduri GU, Muthiah MP, Carratu P, et al. Nuclear factor-κB- and glucocorticoid receptor α- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome: evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005; 12:321-338
42. Liu LY, Sun B, Tian Y, et al. Changes of pulmonary glucocorticoid receptor and phospholipase A2 in sheep with acute lung injury after high dose endotoxin infusion. Am Rev Respir Dis 1993; 148:878-881
43. Liu DH, Su YP, Zhang W, et al. Changes in glucocorticoid and mineralocorticoid receptors of liver and kidney cytosols after pathologic stress and its regulation in rats. Crit Care Med 2002; 30:623-627
44. Kino T, Ichijo T, Chrousos GP. FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors. J Steroid Biochem Mol Biol 2004; 92:357-363
45. Kino T, Chrousos GP. Tumor necrosis factor α receptor- and Fas-associated FLASH inhibit transcriptional activity of the glucocorticoid receptor by binding to and interfering with its interaction with p160 type nuclear receptor coactivators. J Biol Chem 2003; 278:3023-3029
46. Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 174:1319-1326
47. Bateman A, Singh A, Kral T, et al. The immune-hypothalamic-pituitary- adrenal axis. Endocrine Rev 1989; 10:92-112
48. Gaillard RC, Turnill D, Sappino P, et al. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 1990; 127:101-106
49. Richards ML, Caplan RH, Wickus GG, et al. The rapid low-dose (1 microgram) cosyntropin test in the immediate postoperative period: results in elderly subjects after major abdominal surgery. Surgery 1999; 125:431-440
50. Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271
51. Jaattela M, Ilvesmaki V, Voutilainen R, et al. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991; 128:623-629
52. Natarajan R, Ploszay S, Horton R, et al. Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotenisin II induced aldosterone synthesis. Endocrinology 1989; 125:3084-3089
53. Jaattela M, Carpen O, Stenman UH, et al. Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-α. Mol Cell Endocrinol 1990; 68:R31-36
54. Chien JY, Jerng JS, Yu CJ, et al. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 2005; 33:1688-1693
55. van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003; 31:1359-1366
56. van der Voort PH, Gerritsen RT, Bakker AJ, et al. HDL-cholestrol level and cortisol response to synacthen in critically ill patients. Intensive Care Med 2003; 29:2199-2203
57. Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335:1206-1212
58. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med 2003; 31:141-145
59. Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001; 17:25-42
60. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem. Chest 2002; 122:1784-1796
61. Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
62. Arafah BM. Hypothalamic-pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 2006; 91:3725-3745
63. Cohen J, Ward G, Prins J, et al. Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population. Intensive Care Med 2006; 32:1901-1905
64. Venkatesh B, Mortimer RH, Couchman B, et al. Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study. Anaesth Intensive Care 2005; 33:201-209
65. Vogeser M, Briegel J, Jacob K. Determination of serum cortisol by isotope-dilution liquid-chromatography electrospray ionization tandem mass spectrometry with online extraction. Clin Chem Lab Med 2001; 39:944-947
66. Bolland MJ, Chiu WW, Davidson JS, et al. Heterophile antibodies may cause falsely lowered serum cortisol values. J Endocrinol Invest 2005; 28:643-645
67. van Leeuwen HJ, van der Bruggen T, van Asbeck BS, et al. Effect of corticosteroids on nuclear factor-κB activation and hemodynamics in late septic shock. Crit Care Med 2001; 29:1074-1077
68. Thomas JP, el-Shaboury AH. Aldosterone secretion in steroid-treated patients with adrenal suppression. Lancet 1971; 1:623-625
69. Schneider AJ, Voerman HJ. Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids. Intensive Care Med 1991; 17:436-437
70. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
71. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
72. Chawla K, Kupfer Y, Tessler S. Hydrocortisone reverses refractory septic shock [abstract]. Crit Care Med 1999; 27(suppl):A33
73. Oppert M, Schindler R, Husuang C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005; 33:2457-2464
74. Cicarelli DD, Vieira JE, Bensenor FEM. Early dexamethasone treatment for septic shock: a prospective randomized clinical trial. Sao Paulo Med J 2007; 125:237-241
75. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
76. Meduri GU, Marik PE, Chrousos GP, et al. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med 2008; 34:61-69
77. Marik PE, Pastores SM, Kavanaugh BP. Selection bias negates conclusions from the CORTICUS study? N Engl J Med 2008; 358:2069-2070
78. The Acute Respiratory Distress Syndrome Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684
79. Meduri GU. There is no illumination is speculation: additional data in supprt of methyprednisolone treatment in ARDS. Chest 2007; 132:1097-1100
80. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
81. Tremblay L, Valenza F, Ribeiro SP, et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997; 99:944-952
82. Jackson WL Jr. Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock? A critical appraisal. Chest 2005; 127:1031-1038
83. Vinclair M, Broux C, Faure C, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 2008; 34:714-719
84. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003; 167:512-520
85. Kaufmann I, Briegel J, Schliephake F, et al. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Med 2008; 34:344-349
86. Meduri GU, Tolley EA, Chrousos GP, et al. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002; 165:983-991
87. Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infect Immun 2006; 74:5227-5235
88. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251
89. Hotchkiss RS, Tinsley KW, Swanson PE, et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166:6952-6963
90. Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroids in adult head injury: outcomes at 6 months. Lancet 2005; 365:1957-1959
91. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990; 322:1405-1411
92. Hurlbert RJ. The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine 2001; 26:S39-S46
93. Apuzzo ML. Pharmacological therapy after acute cervical spinal cord injury. Neurosurg 2002; 50:S63-S72
94. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. Can Med Assoc J 2003; 168:1145-1146
95. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours in the treatment of acute spinal cord injury: results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. JAMA 1997; 277:1597-1604
96. Lee HM, Weinstein JN, Meller ST, et al. The role of steroids and their effects on phospholipase A2: an animal model of radiculopathy. Spine 1998; 23:1191-1196
97. Liu NK, Zhang YP, Titsworth WL, et al. A novel role of phospholipase A2 in mediating spinal cord secondary injury. Ann Neurol 2006; 59:606-619
98. Meduri GU, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 1995; 107:1062-1073
99. Briegel J, Kellermann W, Forst H, et al. Low-dose hydrocortisone infusion attenuates the systemic inflammatory response syndrome: the Phospholipase A2 Study Group. Clinical Investigator 1994; 72:782-787
100. Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 2007; 167:1655-1663
101. Lekkou A, Karakantza M, Mouzaki A, et al. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004; 11:161-167
102. Loisa P, Parviainen I, Tenhunen J, et al. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care 2007; 11:R21
103. Weber-Carstens S, Deja M, Bercker S, et al. Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients. Intensive Care Med 2007; 33:730-733
104. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105:244-252
105. Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002; 83:37-48
106. Duclos M, Guinot M, Colsy M, et al. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc 2007; 39:1036-1043
107. Mager DE, Lin SX, Blum RA, et al. Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharmacol 2003; 43:1216-1227
108. Yared JP, Starr NJ, Torres FK, et al. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg 2000; 69:1420-1424
109. Yared JP, Bakri MH, Erzurum SC, et al. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial. J Cardiothorac Vasc Anesth 2007; 21:68-75
110. Halonen J, Halonen P, Jarvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 2007; 14:1562-1567
111. Schelling G, Kilger E, Roozendaal B, et al. Stress doses of hydrocortisone, traumatic memories, and symptoms of post-traumatic stress disorder in patients after cardiac surgery: a randomized study. Biol Psychiatr 2004; 55:627-633
112. Kilger E, Weis F, Briegel J, et al. Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Crit Care Med 2003; 31:1068-1074
113. Huang CJ, Lin HC. Association between adrenal insufficiency and ventilator weaning. Am J Respir Crit Care Med 2006; 173:276-280
114. Chaney MA, Nikolov MP, Blakeman B, et al. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg 1998; 87:27-33
115. Chaney MA, Nikolov MP, Blakeman BP, et al. Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation. Ann Thorac Surg 1999; 67:1006-1011
116. Morariu AM, Loef BG, Aarts LP, et al. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting; a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005; 128:2677-2687
117. Schelling G, Roozendaal B, De Quervain DJ. Can posttraumatic stress disorder be prevented with glucocorticoids? Ann NY Acad Sci 2004; 1032:158-166
118. Roozendaal B, Quirarte GL, McGaugh JL. Stress-activated hormonal systems and the regulation of memory storage. Ann New York Acad Sci 1997; 821:247-258
119. McFarlane AC, Atchison M, Yehuda R. The acute stress response following motor vehicle accidents and its relation to PTSD. Ann New York Acad Sci 1997; 821:437-441
120. Delahanty DL, Raimonde AJ, Spoonster E, et al. Injury severity, prior trauma history, urinary cortisol levels, and acute PTSD in motor vehicle accident victims. J Anx Disord 2003; 17:149-164
121. Schelling G, Stoll C, Kapfhammer HP, et al. The effect of stress doses of hydrocortisone during septic shock on post-traumatic stress disorder and health-related quality of life in survivors. Crit Care Med 1999; 27:2678-2683
122. Schelling G, Briegel J, Roozendaal B, et al. The effect of stress doses of hydrocortisone during septic shock on post-traumatic stress disorder in survivors. Biol Psychiatr 2001; 50:978-985
123. Rasaratnam B, Kaye D, Jennings G, et al. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis: a randomized trial. Ann Intern Med 2003; 139:186-193
124. Mookerjee RP, Sen S, Davies NA, et al. Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 2003; 52:1182-1187
125. Tsai MH, Peng YS, Chen YC, et al. Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006; 43:673-681
126. Fernandez J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology 2006; 44:1288-1295
127. Marik PE, Gayowski T, Starzl TE, et al. The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med 2005; 33:1254-1259